BioSpace News Archive

Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its third quarter 2022 financial results on Thursday, November 3, 2022, after the financial markets close.

Evoke Pharma, Inc. today announced that the Company will participate in the 2022 American College of Gastroenterology Annual Scientific Meeting taking place from October 21 – 26, 2022 in Charlotte, North Carolina.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced two new advances in MR-only workflows to advance head and neck cancer radiotherapy imaging and simulation.

Amgen (NASDAQ: AMGN) today announced that it has successfully completed its previously announced acquisition of ChemoCentryx, Inc. (NASDAQ: CCXI).

Corium, LLC and Gurnet Point Capital announced the acquisition of their manufacturing business and a $100 million equity investment by Webster Equity Partners, a healthcare-focused private equity firm that focuses on applying its expertise in the health care services sector to drive sustainability and long term value.

As part of a 320m SEK investment program in biological therapies, one research project will play a pivotal role in making Sweden a major leader in Advanced Therapeutic Medical Products (ATMPs) by 2030.

Novocure (NASDAQ: NVCR) today announced a review article of anti-cancer mechanisms of action of Tumor Treating Fields (TTFields) has been published in the Journal of Molecular Cell Biology (JMCB).

Novocure announced the launch of a campaign intended to drive awareness and understanding of Tumor Treating Fields therapy as a distinct anticancer modality and an emerging cornerstone of solid tumor treatment.

Neonode Inc. (NASDAQ: NEON) is pleased to announce that Elix Systems SA has extended its agreement with Neonode and will increase the use of Neonode’s Touch Sensor Modules to enable touch interaction on displays in medical ultrasound systems.

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated April 9, 2021, to its short form base prospectus dated March 31, 2021.